| 2024/09 - 九個月 人民幣(K¥) | 與去年末期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | |
非流動資產 | ||||||
| 長期股權投資 | 6,500 | 0.00% | 6,500 | 0 | 0 | 0 |
| 投資性房地產 | 0 | -- | 0 | 0 | 0 | 0 |
| 固定資產 | 840,217 | -1.04% | 849,035 | 461,656 | 248,517 | 74,430 |
| 在建工程 | 124,408 | 10.83% | 112,254 | 523,346 | 238,714 | 127,702 |
| 無形資產 | 15,829 | 2.95% | 15,376 | 17,233 | 18,766 | 21,754 |
| 商譽 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動資產 | 603,284 | 5.99% | 569,205 | 563,729 | 569,457 | 144,285 |
| 1,590,239 | 2.44% | 1,552,371 | 1,565,965 | 1,075,454 | 368,171 | |
流動資產 | ||||||
| 貨幣資金 | 762,342 | -26.65% | 1,039,366 | 651,463 | 926,879 | 1,145,491 |
| 應收賬款 | 1,393,196 | -1.23% | 1,410,519 | 1,287,074 | 837,177 | 352,683 |
| 存貨 | 180,436 | 3.98% | 173,536 | 153,646 | 105,493 | 49,916 |
| 其他流動資產 | 24,554 | -26.65% | 33,476 | 52,918 | 73,039 | 231,417 |
| 2,360,528 | -11.15% | 2,656,897 | 2,145,100 | 1,942,587 | 1,779,507 | |
流動負債 | ||||||
| 短期借款 | 216,432 | 13.37% | 190,914 | 109,296 | 0 | 0 |
| 應付票據 | 938 | -76.55% | 4,000 | 17,804 | 0 | 0 |
| 應付帳款 | 5,214 | 66.63% | 3,129 | 16,338 | 6,058 | 5,863 |
| 其他流動負債 | 263,448 | -45.53% | 483,682 | 468,270 | 332,879 | 164,462 |
| 486,032 | -28.71% | 681,725 | 611,708 | 338,937 | 170,325 | |
| 流動資產淨值 | 1,874,496 | -5.10% | 1,975,173 | 1,533,392 | 1,603,650 | 1,609,182 |
| 資產總額減流動負債 | 3,464,735 | -1.78% | 3,527,543 | 3,099,357 | 2,679,104 | 1,977,353 |
非流動負債 | ||||||
| 長期借款 | 0 | -- | 0 | 15,748 | 0 | 0 |
| 應付債券 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動負債 | 9,976 | -26.06% | 13,492 | 7,941 | 8,804 | 2,919 |
| 9,976 | -26.06% | 13,492 | 23,689 | 8,804 | 2,919 | |
總權益 | ||||||
| 實收股本 | 134,650 | 0.00% | 134,650 | 134,650 | 90,000 | 60,000 |
| 儲備項目 | 3,320,109 | -1.75% | 3,379,401 | 2,941,018 | 2,580,301 | 1,914,434 |
| 股東權益 | 3,454,759 | -1.69% | 3,514,052 | 3,075,668 | 2,670,301 | 1,974,434 |
| 非控股權益 | 0 | -- | 0 | 0 | 0 | 0 |
300841 康華生物
按盤價 
58.080 +0.790 (+1.38%)
58.080 +0.790 (+1.38%)| 備註： | 報價延遲最少15分鐘，資料更新時間為 20/12/2024 16:30 |
